Congress expands police grants to buy overdose-reversal drugs

What it does

This bill expands the Byrne JAG grant program—a federal law-enforcement funding stream—to explicitly permit grants to be used for purchasing fentanyl testing kits and opioid reversal agents (like naloxone). Currently, the statute does not list these items as eligible uses; the bill adds them, allowing police departments and other law-enforcement agencies to deploy harm-reduction tools alongside enforcement.

Why we flagged it

The bill's operative mechanism is a straightforward expansion of eligible uses for an existing law-enforcement grant program to include overdose-prevention tools. It is a targeted public-health measure, not a regulatory change or appropriation.

What the text implies

• Byrne JAG grants are discretionary and flow to state/local law enforcement; uptake of fentanyl testing kits and naloxone depends on whether agencies choose to allocate funds to harm reduction rather than enforcement. The bill permits the use but does not mandate it or guarantee funding levels.
• Fentanyl testing kits and naloxone are most effective when paired with education, training, and community trust. The bill does not require training or community engagement, so effectiveness depends on implementation by local agencies.
• Naloxone and fentanyl testing kits are harm-reduction tools that do not address root causes of opioid addiction (treatment access, housing, economic opportunity). The bill expands one tool but does not address systemic gaps.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill removes a barrier to harm-reduction tools (fentanyl testing kits and naloxone) reaching communities by clarifying that law-enforcement grant funds can purchase them. Fentanyl testing kits reduce overdose risk by identifying dangerous drugs; naloxone reverses opioid overdoses and saves lives. Expanding access to these tools, especially in under-resourced communities, is a public-health gain.

Who stands to gain

• manufacturers of fentanyl testing kits
• manufacturers of naloxone/opioid reversal agents
• law-enforcement agencies (via expanded grant flexibility)

Named in the bill

Byrne JAG (Justice Assistance Grant program), Omnibus Crime Control and Safe Streets Act of 1968, 42 U.S.C. § 3751(a)(1)(E), law-enforcement agencies, fentanyl testing kit manufacturers, naloxone manufacturers

Where it stands

3 cosponsors: 3 Republicans.

• Oct 1, 2026 — Introduced · Congress.gov: “Introduced in House”
• Oct 1, 2026 — Referred to House Committee on the Judiciary · Congress.gov: “Referred to the House Committee on the Judiciary”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.